[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100481288":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":37,"locations":43,"responsibleParty":84,"collaborators":86,"id":90,"slug":91,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":24,"eligibilityCriteria":96,"healthyVolunteers":97,"sex":98,"minAge":99,"maxAge":24,"enrollmentInfo":100,"targetDuration":24,"studyType":103,"phases":104,"briefSummary":106,"conditions":107,"keywords":24,"overallStatus":46,"whyStopped":24,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Yale University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Athena Strategy","EXPERIMENTAL","Virtual care model that includes direct synchronous videoconferencing with a provider, telephone\u002F texting communication, electronic health records, e-prescribing for the purposes of delivering PrEP and medications for opioid use disorder. This is combined with a decision aid for PrEP",[13],"Combination Product: Athena strategy",{"label":15,"type":16,"description":17,"interventionNames":18},"Decision Aid","ACTIVE_COMPARATOR","Decision aid for PrEP tailored for justice-involved women with opioid use disorder",[19],"Behavioral: Decision Aid",[21,25],{"type":22,"name":15,"description":17,"armGroupLabels":23,"otherNames":24},"BEHAVIORAL",[15],null,{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":24},"COMBINATION_PRODUCT","Athena strategy","eHealth for integrated PrEP\u002Fmedications for opioid use disorder + decision aid",[9],[31,34],{"name":32,"affiliation":5,"role":33},"Carolina Price, MPA","STUDY_DIRECTOR",{"name":35,"affiliation":5,"role":36},"Jaimie P Meyer, MD, MS, FACP","PRINCIPAL_INVESTIGATOR",[38],{"name":39,"role":40,"phone":41,"phoneExt":24,"email":42},"Adrienne L Marable","CONTACT","(203) 737-3393","gcat5@yale.edu",[44,68],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"University of Alabama in Birmingham","RECRUITING","Birmingham","Alabama","35294","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-86.80249,33.52066,{"lat":56,"lon":55},[59,63,65],{"name":60,"role":40,"phone":61,"phoneExt":24,"email":62},"Ellen Eaton","205-934-3411","eeaton@uabmc.edu",{"name":64,"role":36,"phone":24,"phoneExt":24,"email":24},"Ellen Eaton, MD",{"name":66,"role":67,"phone":24,"phoneExt":24,"email":24},"Karen Cropsey, PsyD","SUB_INVESTIGATOR",{"facility":5,"status":46,"city":69,"state":70,"zip":71,"country":50,"countryCode":51,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"New Haven","Connecticut","06519",{"type":53,"coordinates":73},[74,75],-72.92816,41.30815,{"lat":75,"lon":74},[78,81,82],{"name":32,"role":40,"phone":79,"phoneExt":24,"email":80},"203-499-8075","carolina.price@yale.edu",{"name":35,"role":36,"phone":24,"phoneExt":24,"email":24},{"name":83,"role":67,"phone":24,"phoneExt":24,"email":24},"Fredrick L Altice, MD",{"type":85,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[87],{"name":88,"class":89},"National Institute on Drug Abuse (NIDA)","NIH","100481288","phase-4-integrated-e-health-electronic-health-for-hiv-and-substance-use-disorders-in-justice-involved-women-100481288",false,"NCT05547048","Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women","Integrated eHealth for HIV and Substance Use Disorders in Justice Involved Women","Inclusion Criteria:\n\n* woman\n* have access to a working mobile or landline phone\n* Lifetime CJ-involvement (probation, parole, intensive pretrial or community supervision, or release from prison\u002Fjail)\n* are confirmed HIV-negative by point-of-care 3rd generation HIV antibody test\n* meet clinical criteria for PrEP\n* have opioid use disorder (regardless of baseline treatment status)\n\nExclusion Criteria:\n\n* unable or unwilling to provide informed consent\n* pregnant or breast-feeding\n* currently taking PrEP at the time of study enrollment\n* not comfortable conversing in English or Spanish.",true,"FEMALE","18 Years",{"count":101,"type":102},250,"ESTIMATED","INTERVENTIONAL",[105],"PHASE4","The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ).\n\nThis study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.",[108,109,110],"HIV","Opioid Use Disorder","eHealth","2026-06-01",{"date":113,"type":114},"2026-06-03","ACTUAL",{"date":116,"type":114},"2023-07-25",{"date":118,"type":102},"2027-04-01",{"name":5,"class":6},2]